Massimo MASSERINI
Università di Milano-Bicocca - Amypopharma

Massimo Masserini is full professor of Biochemistry and Molecular Biology at the School of Medicine, University Milano-Bicocca, Milano, Italy.  He is Head of the Nanomedicine Center (NANOMIB) of the same University and Director of the International School of Nanomedicine at EMCSC (Erice, Italy).  He has published more than 150 articles on the main Journals of Biochemistry, Neuroscience and Nanomedicine and is co-inventor of  2 families of patents concerning the use of nanoparticles for treatment of neurodegenerative diseases. MM coordinated the FP7 project “NAD, nanoparticles for therapy and diagnosis of Alzheimer Disease”. MM is also CEO of AmypoPharma, a Spin-off Company of the University Milano-Bicocca aiming  to carry nanoparticles for treatment of Alzheimer disease to the Clinical phase.    

Back to TS.VI.C